Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-10

Clinical Trial Update: An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial of pracinostat with azacitidine in adults with acute myeloid leukemia was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)
  • Pracinostat (pracinostat)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2022-03-10